Literature DB >> 26393084

Enhancing the impact of antiretroviral scale-up on the HIV-associated tuberculosis epidemic in Malawi.

Stephen D Lawn1.   

Abstract

Entities:  

Year:  2014        PMID： 26393084      PMCID： PMC4533823          DOI： 10.5588/pha.14.0067

Source DB:  PubMed          Journal:  Public Health Action        ISSN： 2220-8372


× No keyword cloud information.
  5 in total

1.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

2.  Decline in national tuberculosis notifications with national scale-up of antiretroviral therapy in Malawi.

Authors:  H Kanyerere; A Mganga; A D Harries; K Tayler-Smith; A Jahn; F M Chimbwandira; J Mpunga
Journal:  Public Health Action       Date:  2014-06-21

3.  Treatment outcomes of patients with HIV and tuberculosis.

Authors:  Payam Nahid; Leah C Gonzalez; Irina Rudoy; Bouke C de Jong; Alon Unger; L Masae Kawamura; Dennis H Osmond; Philip C Hopewell; Charles L Daley
Journal:  Am J Respir Crit Care Med       Date:  2007-02-08       Impact factor: 21.405

4.  Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.

Authors:  Molebogeng X Rangaka; Robert J Wilkinson; Andrew Boulle; Judith R Glynn; Katherine Fielding; Gilles van Cutsem; Katalin A Wilkinson; Rene Goliath; Shaheed Mathee; Eric Goemaere; Gary Maartens
Journal:  Lancet       Date:  2014-05-13       Impact factor: 79.321

5.  Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.

Authors:  Ankur Gupta; Robin Wood; Richard Kaplan; Linda-Gail Bekker; Stephen D Lawn
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.